SE7509703L - - Google Patents

Info

Publication number
SE7509703L
SE7509703L SE7509703A SE7509703A SE7509703L SE 7509703 L SE7509703 L SE 7509703L SE 7509703 A SE7509703 A SE 7509703A SE 7509703 A SE7509703 A SE 7509703A SE 7509703 L SE7509703 L SE 7509703L
Authority
SE
Sweden
Application number
SE7509703A
Other versions
SE408300B (sv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2449167A external-priority patent/DE2449167C2/de
Priority claimed from DE19752527723 external-priority patent/DE2527723A1/de
Application filed filed Critical
Publication of SE7509703L publication Critical patent/SE7509703L/xx
Publication of SE408300B publication Critical patent/SE408300B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7509703A 1974-10-16 1975-09-01 Sett att framstella nya dipeptidderivat SE408300B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2449167A DE2449167C2 (de) 1974-10-16 1974-10-16 N-Acyl-L-histidyl-L-prolinamide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE19752527723 DE2527723A1 (de) 1975-06-21 1975-06-21 Verfahren zur herstellung von dipeptid-derivaten

Publications (2)

Publication Number Publication Date
SE7509703L true SE7509703L (enExample) 1976-04-20
SE408300B SE408300B (sv) 1979-06-05

Family

ID=25767820

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7509703A SE408300B (sv) 1974-10-16 1975-09-01 Sett att framstella nya dipeptidderivat

Country Status (12)

Country Link
US (1) US4045556A (enExample)
JP (1) JPS609518B2 (enExample)
CA (1) CA1056818A (enExample)
CH (1) CH616913A5 (enExample)
DK (1) DK149063C (enExample)
ES (1) ES441788A1 (enExample)
FR (1) FR2287916A1 (enExample)
GB (1) GB1519636A (enExample)
IE (1) IE41803B1 (enExample)
NL (1) NL183764C (enExample)
SE (1) SE408300B (enExample)
YU (1) YU39330B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4125578A (en) * 1977-11-09 1979-05-17 Merck & Co Inc Tripeptides
US4182856A (en) * 1978-04-25 1980-01-08 Miles Laboratories, Inc. Reagents for use in binding assays to determine diphenylhydantoin
HU180926B (en) * 1979-06-28 1983-05-30 Richter Gedeon Vegyeszet Process for preparing trh analogues,tripeptide amides infectives on the central nerve sysrhem
GB2146026A (en) * 1983-09-07 1985-04-11 Tanabe Seiyaku Co Peptides and process for preparing the same
US4608365A (en) * 1984-03-30 1986-08-26 University Of Southern California Treatment of neurologic functions
IL75641A (en) * 1984-07-10 1990-11-05 Tanabe Seiyaku Co 1-methyl-4,5-dihydro-orotyl-histidyl-prolinamide,its preparation and pharmaceutical compositions comprising it
IE58849B1 (en) * 1984-12-18 1993-11-17 Gruenenthal Chemie Use of dipeptide derivatives for the manufacture of medicaments for the treatment of patients with amyotrophic lateral sclerosis
GB2171101A (en) * 1985-02-20 1986-08-20 Tanabe Seiyaku Co Peptide and processes for preparation of the same
US5151497A (en) * 1989-02-21 1992-09-29 Japan Tobacco Inc. Histidyl peptide derivatives
AU5365494A (en) * 1992-10-22 1994-05-09 Peter G. Thomas New method of protecting central nervous system against damage resulting from cerebrovascular or neuronal compromise
BE1007183A3 (fr) * 1993-06-18 1995-04-18 Solvay Ureines derivees d'alpha, omega-diaminoacides et procede pour leur preparation.
AU714270B2 (en) * 1995-10-24 1999-12-23 Gruenenthal Gmbh Method of inhibiting sleep apnea
AU713030B2 (en) * 1995-10-24 1999-11-18 Gruenenthal Gmbh Method of adjusting the circadian rhythm of a mammal
DE10025949A1 (de) * 2000-05-26 2001-11-29 Gruenenthal Gmbh Arzneimittel zur Bekämpfung von Atemdepression
TWI285110B (en) 2000-08-31 2007-08-11 Shionogi & Co Parkinson disease therapeutic agent
KR101137503B1 (ko) * 2009-07-14 2012-04-20 웰이앤씨 주식회사 고분자 고체 지지체를 이용한 히스티딜-프롤린아미드 유도체의 제조 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5714337B2 (enExample) * 1973-02-23 1982-03-24

Also Published As

Publication number Publication date
SE408300B (sv) 1979-06-05
NL7510288A (nl) 1976-04-21
DK149063C (da) 1986-06-16
NL183764B (nl) 1988-08-16
NL183764C (nl) 1989-01-16
DK149063B (da) 1986-01-06
YU39330B (en) 1984-10-31
US4045556A (en) 1977-08-30
ES441788A1 (es) 1977-06-16
FR2287916B1 (enExample) 1978-07-28
IE41803L (en) 1976-04-16
GB1519636A (en) 1978-08-02
DK463775A (da) 1976-04-17
FR2287916A1 (fr) 1976-05-14
JPS609518B2 (ja) 1985-03-11
YU232475A (en) 1982-02-28
JPS5165775A (enExample) 1976-06-07
CA1056818A (en) 1979-06-19
CH616913A5 (enExample) 1980-04-30
IE41803B1 (en) 1980-03-26

Similar Documents

Publication Publication Date Title
DK113875A (enExample)
FI751109A7 (enExample)
DK140730C (enExample)
FR2287916B1 (enExample)
DK426275A (enExample)
DK167575A (enExample)
DK364274A (enExample)
DK285574A (enExample)
DK24275A (enExample)
FI49813B (enExample)
CU34062A (enExample)
DK664674A (enExample)
DK141174A (enExample)
CS173907B1 (enExample)
FI199374A7 (enExample)
CS166132B1 (enExample)
CS169558B1 (enExample)
FI304074A7 (enExample)
DK463874A (enExample)
DD121810A5 (enExample)
DD110059A1 (enExample)
DD111536A1 (enExample)
CH573573A5 (enExample)
CH599262A5 (enExample)
CH602315A5 (enExample)

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7509703-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7509703-0

Format of ref document f/p: F